医学分子生物学杂志 ›› 2026, Vol. 23 ›› Issue (5): 523-530.doi: 10.3870/j.issn.1672-8009.2026.05.006

• 论著 • 上一篇    下一篇

慢病毒载体介导miR-195低表达调控BMMSCs成骨分化及血管生成

丁刘闯, 裴培, 姬晓炜   

  1. 新疆医科大学第一附属医院口腔修复种植科 乌鲁木齐市, 830013
  • 收稿日期:2025-12-12 出版日期:2026-09-30 发布日期:2026-09-30
  • 通讯作者: 姬晓炜(E-mail:31891275@qq.com)
  • 基金资助:
    “青年科研起航”基金青年项目(No.2024YFY-QKQN-86)

Effect of Lentiviral Vector-Mediated Knockdown of miR-195 on Osteogenic and Angiogenic Differentiation of BMMSCs

DING Liuchuang, PEI Pei, JI Xiaowei   

  1. Department of Prosthodontics and Implantology, First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830013, China
  • Received:2025-12-12 Online:2026-09-30 Published:2026-09-30
  • Contact: JI Xiaowei (E-mail:31891275@qq.com )
  • Supported by:
    “Youth Research Start-up” Fund for Young Scholars(No.2024YFY-QKQN-86)

摘要: 目的 探讨慢病毒载体介导微小RNA-195(miR-195)低表达对骨髓间充质干细胞(bone marrow mesenchymal stem cells,BMMSCs)成骨分化与成血管分化的调控作用及可能机制。方法 将人BMMSCs分为空白对照组、inhibitor-NC组(慢病毒转染阴性对照NC序列)、miR-195-inhibitor组(慢病毒转染miR-195抑制序列)。采用RNA荧光原位杂交检测miR-195表达定位,CCK-8法检测增殖活力;碱性磷酸酶(alkaline phosphatase,ALP)染色、茜素红染色及Runt相关转录因子2(Runt-related transcription factor 2,Runx2)免疫荧光评估成骨分化;血管生成拟态实验结合qRT-PCR检测血管内皮生长因子(vascular endothelial growth factor,VEGF)、ALP、Runx2、VEGF受体2(VEGF receptor 2,VEGFR2)、促血管生成素(angiopoietin-1,Ang-1)及Wnt/β-catenin通路相关分子Wnt3a、Wnt10b、β-连环蛋白(β-catenin)、成骨细胞特异性转录因子(Osterix)的mRNA水平,蛋白质印迹检测上述通路及成骨相关蛋白表达。结果 与对照组相比,miR-195-inhibitor组miR-195表达显著下调(P均<0.05),增殖活力、ALP活性(4.15±0.52 vs 1.00±0.15)、茜素红阳性率(64.67 %±7.78 % vs 31.86 %±2.24 %)、Runx2荧光强度(852.38±122.70 vs 121.31±12.16 RFU)、管状结构长度(218.60±24.75 vs 49.80±5.25 μm/视野),VEGF、ALP、Runx2、VEGFR2、Ang-1、Wnt3a、Wnt10b、β-catenin、Osterix mRNA水平及Wnt3a、Wnt10b、β-catenin、Osterix蛋白水平均显著上调(P均<0.05),而与空白对照组比较,inhibitor-NC组的上述指标差异均无统计学意义(P>0.05)。结论 慢病毒载体介导的miR-195低表达通过激活Wnt/β-catenin信号通路,协同促进BMMSCs成骨与成血管分化。

关键词: 慢病毒载体, 微小RNA-195, 骨髓间充质干细胞, 成骨分化, 成血管分化

Abstract: Objective To investigate the regulatory effect and potential mechanism of lentiviral vector-mediated microRNA-195 (miR-195) downregulation on osteogenic and angiogenic differentiation of bone marrow mesenchymal stem cells (BMMSCs). Methods Human BMMSCs were divided into three groups: blank control group, inhibitor-negative control (NC) group (transfected with lentiviral NC sequence), and miR-195-inhibitor group (transfected with lentiviral miR-195 inhibitor sequence). The expression and localization of miR-195 were detected by RNA fluorescence in situ hybridization. Cell proliferation was measured by CCK-8 assay. Osteogenic differentiation was evaluated by alkaline phosphatase (ALP) staining, alizarin red staining, and Runt-related transcription factor 2 (Runx2) immunofluorescence. Tube formation assay was performed for angiogenesis assessment. The mRNA levels of vascular endothelial growth factor (VEGF), ALP, Runx2, VEGF receptor 2 (VEGFR2), angiopoietin-1 (Ang-1), and Wnt/β-catenin pathway-related molecules (Wnt3a, Wnt10b, β-catenin, Osterix) were determined by qRT-PCR. The protein expression of the above pathway and osteogenesis-related molecules was detected by Western blotting. Results Compared with the control groups, the miR-195-inhibitor group showed significantly decreased miR-195 expression (all P<0.05), and markedly increased cell proliferation, ALP activity (4.15±0.52 vs 1.00±0.15), alizarin red positive rate (64.67%±7.78% vs 31.86%±2.24%), Runx2 fluorescence intensity (852.38±122.70 vs 121.31±12.16 RFU), and tubular structure length (218.60±24.75 vs 49.80±5.25 μm/field). The mRNA levels of VEGF, ALP, Runx2, VEGFR2, Ang-1, Wnt3a, Wnt10b, β-catenin, and Osterix, as well as the protein levels of Wnt3a, Wnt10b, β-catenin, and Osterix were all significantly upregulated (all P<0.05). There were no significant differences in the above indices between the inhibitor-NC group and the blank control group (P>0.05). Conclusion Lentiviral-mediated miR-195 downregulation synergistically promotes osteogenic and angiogenic differentiation of BMMSCs via activating the Wnt/β-catenin signaling pathway.

Key words: lentivirus, microRNA-195, bone marrow mesenchymal stem cell, osteogenic differentiation, angiogenic differentiation

中图分类号: